Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-26 @ 1:17 AM
Study NCT ID:
NCT01025934
Status:
COMPLETED
Last Update Posted:
2009-12-04
First Post:
2009-12-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
Sponsor:
University of Campania Luigi Vanvitelli
Organization:
Study Overview
Official Title:
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: